Author

Anne M. van der Waaij

FLUORESCENTLY LABELLED VEDOLIZUMAB VISUALIZES LOCAL DRUG DISTRIBUTION DURING COLONOSCOPY AND IDENTIFIES MUCOSAL TARGET CELLS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
FLUORESCENTLY LABELLED VEDOLIZUMAB VISUALIZES LOCAL DRUG DISTRIBUTION DURING COLONOSCOPY AND IDENTIFIES MUCOSAL TARGET CELLS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Anne M. van der Waaij  et al.

QUANTITATIVE FLUORESCENCE MOLECULAR ENDOSCOPY USING CETUXIMAB-800CW TO EVALUATE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER; LESSONS LEARNED
QUANTITATIVE FLUORESCENCE MOLECULAR ENDOSCOPY USING CETUXIMAB-800CW TO EVALUATE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER; LESSONS LEARNED

Anne M. van der Waaij  et al.

NOVEL ULTRASOUND-GUIDED QUANTITATIVE FLUORESCENCE MOLECULAR ENDOSCOPY FOR RESPONSE MONITORING IN PATIENTS WITH ESOPHAGEAL CANCER AFTER NEOADJUVANT CHEMORADIOTHERAPY
NOVEL ULTRASOUND-GUIDED QUANTITATIVE FLUORESCENCE MOLECULAR ENDOSCOPY FOR RESPONSE MONITORING IN PATIENTS WITH ESOPHAGEAL CANCER AFTER NEOADJUVANT CHEMORADIOTHERAPY

Anne M. van der Waaij  et al.

BEVACIZUMAB-800CW FLUORESCENCE MOLECULAR ENDOSCOPY IMPROVES EARLY CANCER DETECTION AND STANDARDIZATION IN BARRETT’S ESOPHAGUS SURVEILLANCE
BEVACIZUMAB-800CW FLUORESCENCE MOLECULAR ENDOSCOPY IMPROVES EARLY CANCER DETECTION AND STANDARDIZATION IN BARRETT’S ESOPHAGUS SURVEILLANCE

Anne M. van der Waaij  et al.

Item 1 - 4 / 4
1